Relationship between fat mass and obesity-associated gene expression and type 2 diabetes mellitus severity

Wang,Qiuling; Wang,Jinhuan; Lin,Haixia; Huo,Xuechen; Zhu,Qiaoling; Zhang,Min

doi:10.3892/etm.2018.5752

Relationship between fat mass and obesity-associated gene expression and type 2 diabetes mellitus severity

Authors:
- Qiuling Wang
- Jinhuan Wang
- Haixia Lin
- Xuechen Huo
- Qiaoling Zhu
- Min Zhang
View Affiliations

Affiliations: Department of Endocrinology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China, Department of Health, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China, Department of Biliary Surgery, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China, Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China, Neurological Intensive Care Unit, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China
Published online on: January 15, 2018 https://doi.org/10.3892/etm.2018.5752
Pages: 2917-2921
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study sought to investigate any correlation between fat mass and obesity-associated gene (FTO) expression and the severity of type 2 diabetes mellitus (T2DM). In total 110 patients newly diagnosed with T2DM in the outpatient department of Yantai Yuhuangding Hospital between September 2016 and March 2017 were selected as study subjects and were divided into severe (58 cases) and mild groups (52 cases) according to T2DM severity. Patients in the severe group were followed up for 12 weeks. An additional 60 healthy individuals were selected to serve as the normal control group. Fasting plasma glucose (FPG), fasting insulin (FINs), fasting C-peptide (FCP), glycosylated hemoglobin (HbA1c) and homeostasis model assessment of insulin resistance (HOMA-IR) were examined for every patient in the study. Real-time polymerase chain reaction (RT-PCR) was used to detect FTO messenger ribonucleic acid (mRNA) expression levels in patient peripheral blood lymphocytes. Western blotting was used to detect serum FTO protein expression levels, upon which the correlation between FTO protein levels and all other indices were analyzed. Compared with the normal control group, both T2DM groups showed significantly increased waist circumferences, hip circumferences, body mass indexes (BMIs), blood glucose indexes (FPG, FCP, HbA1c, FINs, HOMA-IR) and FTO mRNA/protein levels (p<0.05). Additionally, the increases presented by the severe T2DM group were significantly greater than those presented by the mild T2DM group (p<0.05). After 12 weeks of treatment, the severe T2DM group showed decreased BMI, blood glucose index and FTO protein expression (p<0.05). FTO protein expression in T2DM patients was higher than in healthy controls, with severe patients showing greater expression levels than mild group patients. FTO expression was positively correlated with BMI, waist circumference, chest circumference, FPG, FCP, HbA1c, FINs and HOMA-IR. Therefore, FTO expression can serve as a marker for the clinical diagnosis and treatment of T2DM.

View Figures

View References

1	Dandona P, Aljada A and Bandyopadhyay A: Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol. 25:4–7. 2004. View Article : Google Scholar : PubMed/NCBI
2	Sheehan MT: Current therapeutic options in type 2 diabetes mellitus: A practical approach. Clin Med Res. 1:189–200. 2003. View Article : Google Scholar : PubMed/NCBI
3	Ballantyne GH, Gumbs A and Modlin IM: Changes in insulin resistance following bariatric surgery and the adipoinsular axis: Role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg. 15:692–699. 2005. View Article : Google Scholar : PubMed/NCBI
4	Imamura M and Maeda S: Genetics of type 2 diabetes: The GWAS era and future perspectives (Review). Endocr J. 58:723–739. 2011. View Article : Google Scholar : PubMed/NCBI
5	Loos RJ and Yeo GS: The bigger picture of FTO: The first GWAS-identified obesity gene. Nat Rev Endocrinol. 10:51–61. 2014. View Article : Google Scholar : PubMed/NCBI
6	Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C, Glunk V, Sousa IS, Beaudry JL, Puviindran V, et al: FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med. 373:895–907. 2015. View Article : Google Scholar : PubMed/NCBI
7	Hinney A, Nguyen TT, Scherag A, Friedel S, Brönner G, Müller TD, Grallert H, Illig T, Wichmann HE, Rief W, et al: Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One. 2:e13612007. View Article : Google Scholar : PubMed/NCBI
8	Wang J, Mei H, Chen W, Jiang Y, Sun W, Li F, Fu Q and Jiang F: Study of eight GWAS-identified common variants for association with obesity-related indices in Chinese children at puberty. Int J Obes. 36:542–547. 2012. View Article : Google Scholar
9	Abarin T, Yan Wu Y, Warrington N, Lye S, Pennell C and Briollais L: The impact of breastfeeding on FTO-related BMI growth trajectories: An application to the Raine pregnancy cohort study. Int J Epidemiol. 41:1650–1660. 2012. View Article : Google Scholar : PubMed/NCBI
10	Kunji ER, Aleksandrova A, King MS, Majd H, Ashton VL, Cerson E, Springett R, Kibalchenko M, Tavoulari S, Crichton PG, et al: The transport mechanism of the mitochondrial ADP/ATP carrier. Biochim Biophys Acta. 1863:2379–2393. 2016. View Article : Google Scholar : PubMed/NCBI
11	Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, et al Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC), ; European Association for the Study of Diabetes (EASD), : Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. Eur Heart J. 28:88–136. 2007.PubMed/NCBI
12	Ribola FA, Cançado FB, Schoueri JH, De Toni VF, Medeiros VH and Feder D: Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 21:199–211. 2017.PubMed/NCBI
13	Szulinska M, Gibas-Dorna M, Miller-Kasprzak E, Suliburska J, Miczke A, Walczak-Gałezewska M, Stelmach-Mardas M, Walkowiak J and Bogdanski P: Spirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with well-treated hypertension: A randomized double-blind placebo-controlled study. Eur Rev Med Pharmacol Sci. 21:2473–2481. 2017.PubMed/NCBI
14	Miyazaki Y, Mahankali A and Matsuda M: Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes mellitus (T2DM). Diabetes. 5:2992000.
15	Bhat A, Koul A, Rai E, Sharma S, Dhar MK and Bamezai RN: PGC-1α Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: A replicate case-control study. Hum Genet. 121:609–614. 2007. View Article : Google Scholar : PubMed/NCBI
16	Freathy RM, Timpson NJ, Lawlor DA, Pouta A, Ben-Shlomo Y, Ruokonen A, Ebrahim S, Shields B, Zeggini E, Weedon MN, et al: Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes. 57:1419–1426. 2008. View Article : Google Scholar : PubMed/NCBI
17	Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, et al: The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 318:1469–1472. 2007. View Article : Google Scholar : PubMed/NCBI
18	Guo J, Ren W, Li A, Ding Y, Guo W, Su D, Hu C, Xu K, Chen H, Xu X, et al: Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease. Dig Dis Sci. 58:1004–1009. 2013. View Article : Google Scholar : PubMed/NCBI
19	Robertson RP, Harmon J, Tran PO, Tanaka Y and Takahashi H: Glucose toxicity in β-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 52:581–587. 2003. View Article : Google Scholar : PubMed/NCBI
20	Kajimoto Y and Kaneto H: Role of oxidative stress in pancreatic β-cell dysfunction. Ann N Y Acad Sci. 1011:168–176. 2004. View Article : Google Scholar : PubMed/NCBI
21	Speakman JR, Rance KA and Johnstone AM: Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity (Silver Spring). 16:1961–1965. 2008. View Article : Google Scholar : PubMed/NCBI
22	Wåhlén K, Sjölin E and Hoffstedt J: The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res. 49:607–611. 2008. View Article : Google Scholar : PubMed/NCBI